Providing nearly 700 products to patients worldwide
We create high-quality, affordable generic medicines, and make them accessible to people who need them. We have a broad product range and a growing pipeline of new medicines for treating a wide range of diseases. Therapeutic categories include anti-infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory.
~700
Products on the market
50+
Countries
3
Distinct businesses
Related news
Hikma launches Imatinib Mesylate Tablets
29 October 2018
Hikma launches AdriamycinTM (DOXOrubicin HCl) for Injection, USP
17 September 2018
Hikma launches Sterile Water for Injection, USP
13 August 2018